In April, 2025, Demis Hassabis, the Nobel Prize-winning CEO of Google DeepMind, appeared on the US television show 60 Minutes and suggested that all diseases could be curable with the help of ...

Google DeepMind is now unleashing the local model as a standalone VLA, and it's surprisingly robust. The new Gemini Robotics On-Device model is only a little less accurate than the hybrid version.

A New Era of Research with Health Studio Clinical trials are the backbone of medical advancement but they’ve historically ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Google on Thursday announced the second cohort to take part in its AI Academy: American Infrastructure, which seeks to ...

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...

Numerous Google Cloud services, including those used widely within healthcare, such as Google Vertex AI Online Prediction, Dialogflow CX, Agent Assist and Contact Center AI, were down for nearly four ...

Isomorphic Labs, a drug discovery company spun out of Google ... trials for drugs designed with the help of Artificial Intelligence. If this goes as planned, it will be a significant milestone in ...

AI-powered drug company spun out of Google’s DeepMind says human trials are ‘very close’ After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials.